Alnylam's RNAi therapy targeting antithrombin improves clotting in patients with hemophilia Jan. 16, 2015 No Comments
FDA approves Savaysa for prevention of embolism and stroke in non-valvular atrial fibrillation Jan. 9, 2015 No Comments
RSS